Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties.
By D. Warheit, T. Webb, K. L. Reed, S. Frerichs, Christie M. Sayes. Toxicology, 2007
650 citations recorded by the source corpus.
Subfields: Health, Toxicology and Mutagenesis, Materials Chemistry, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/97649f77fe34d3496e55aef60ff7b9da72a6e3ef
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Health, Toxicology and Mutagenesis
In Materials Chemistry
- Bengt Fadeel
- A. Garcia‐Bennett
- P. Biswas
- Jingkun Jiang
- G. Oberdörster
- L. Reijnders
- Sumit Arora
- Wahajuddin
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Titanium dioxide nanoparticles: a review of current toxicological data (2013, background): “this increased catalytic activity to TiO2 NPs to their high surface area, while others attribute it to TiO2 NPs being predominantly anatase rather than rutile [18,19].”
- Evaluating the Control Banding Nanotool: a qualitative risk assessment method for controlling nanoparticle exposures (2009, background): “anatase [ rutile) that is the toxic differential and that surface area alone is not enough to address pulmonary exposure (Liao et al. 2008; Warheit et al. 2007b ).”
- Occupational exposure to titanium dioxide (2011, background): “In a pulmonary toxicity study in rats, the surface activity of the TiO 2 particle (related to crystal structure, passivation, and acidity) was associated with the inflammation and cell proliferation responses at early time points, but not at the later time points [Warheit et al. 2007].”
- Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. (2010, background): “Titania nanoparticles of various sizes have been extensively studied in recent years andmay be considered as benchmark particles against which other particles can be compared [103,104].”
- Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies (2009, background): “In many toxicological studies, the IS of the buffer solution to disperse nanoparticles for in vitro and in vivo tests is often higher than 0.1 M (Long et al. 2006; Warheit et al. 2007; Sager et al. 2007; Murdock et al. 2008).”
- The release of TiO2 and SiO2 nanoparticles from nanocomposites (2009, background): “[8,16,75,76], may in turn affect hazard [1,48,49,51,67,77].”